See related Galvus tab information |
|
Manufacturer |
Novartis |
Distributor |
Zuellig |
Contents |
Vildagliptin |
Indications |
Adjunct to diet & exercise to improve glycaemic control in patients w/ type 2 DM.
Click to view Galvus detailed prescribing infomation |
Dosage |
As monotherapy & in dual combination w/ metformin or a thiazolidinedione 1 tab once daily (morning) or bid (morning & evening). In combination w/ a sulfonylurea 1 tab once daily in the morning.
Click to view Galvus detailed prescribing infomation |
Overdosage |
View Galvus overdosage for action to be taken in the event of an overdose. |
Administration |
May be taken with or without food |
Contraindications |
[Click for Galvus detailed prescribing infomation] |
Special Precautions |
Type 1 diabetes or diabetic ketoacidosis. Moderate or severe renal impairment, end-stage renal disease, ALT or AST >2.5 x ULN, hepatic impairment. Monitor liver function. Do not reinitiate following w/drawal of treatment & liver function test return to normal. Childn <18 yr. Pregnancy, lactation.
Click to view Galvus detailed prescribing infomation |
Adverse Drug Reactions |
Dizziness, tremor, headache, asthenia, wt increase, peripheral oedema, nausea, flatulence, GERD, decreased blood glucose.
View ADR Monitoring Form |
Drug Interactions |
[Click for Galvus detailed prescribing infomation]
View more drug interactions with Galvus |
Description |
View Galvus description for details of the chemical structure and excipients (inactive components). |
Mechanism of Action |
View Galvus mechanism of action for pharmacodynamics and pharmacokinetics details. |
Presentation/Packing |
Form |
Packing |
Photo |
Galvus tablet |
Galvus 50 mg x 4 x 14's |
 |
|
|
Manufacturer: |
Novartis |
Distributor: |
Zuellig |
|
|

|
|
|